Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
Background: TNFα inhibitors are regularly used to treat autoimmune diseases. Tuberculosis (TB) and viral hepatitis B are considered potential infectious complications, and screening and surveillance are therefore recommended. Current guidelines do not take into account regional differences in endemi...
Main Authors: | Nina Jahnich, Peter D. Arkwright |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1046306/full |
Similar Items
-
New antiviral agents and new treatments on the horizon for the management of viral hepatitis
by: M. Sönmezoğlu
Published: (2011-12-01) -
Incidence of viral hepatitis in Brazil from 2009 to 2018: an epidemiological study of confirmed cases of viral hepatitis
by: Alessandra Pereira da Silva, et al.
Published: (2020-12-01) -
EPIDEMIOLOGICAL CHARACTERISTIC OF VIRAL HEPATITIS B AND C IN THE HEMODIALYSIS UNITS IN SAINT-PETERSBURG IN MODERN TIME. Part 1. Registration of hemo-contact viral hepatitis and serological markers of HBV and HCV infections in patients of hemodialysis unit
by: S. L. Mukomolov, et al.
Published: (2014-06-01) -
Analysis of medical and social factors affecting the formation and course of co-infection HIV, tuberculosis and viral hepatitis
by: O. V. Azovtseva, et al.
Published: (2020-02-01) -
Prevention of Viral Hepatitis
by: Neşe SALTOĞLU
Published: (2001-09-01)